SNOA Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc is a speciality pharmaceutical company. It develops,identifies and commercialises therapies for dermatologic diseases.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/25/2007
Outstanding shares:  3,097,674
Average volume:  444,944
Market cap:   $16,510,602
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    83558L204
ISIN:        US83558L2043
Valuation   (See tab for details)
PE ratio:   -3.09
PB ratio:   0.70
PS ratio:   1.27
Return on equity:   -70.42%
Net income %:   -62.11%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy